{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:38:28Z","timestamp":1794634708635,"version":"4.9.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1111\/bjd.20136","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T04:54:48Z","timestamp":1617857688000},"page":"935-944","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The risk of malignancy in patients with secukinumab\u2010treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow\u2010up"],"prefix":"10.1093","volume":"185","author":[{"given":"M.","family":"Lebwohl","sequence":"first","affiliation":[{"name":"Kimberly and Eric J. Waldman Department of Dermatology Icahn School of Medicine at Mount Sinai New York City NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Deodhar","sequence":"additional","affiliation":[{"name":"Oregon Health &amp; Science University Portland OR USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-4427","authenticated-orcid":false,"given":"C.E.M.","family":"Griffiths","sequence":"additional","affiliation":[{"name":"The Dermatology Centre The University of Manchester Manchester Academic Health Science Centre Salford Royal NHS Foundation Trust Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Menter","sequence":"additional","affiliation":[{"name":"Division of Dermatology Baylor Scott &amp; White Health Dallas TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Poddubnyy","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology Infectious Diseases and Rheumatology, Charit\u00e9, Universit\u00e4tsmedizin Berlin, Germany, and Epidemiology Unit German Rheumatism Research Centre Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Bao","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation East Hanover NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Jehl","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Marfo","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Primatesta","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Shete","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation East Hanover NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Mease","sequence":"additional","affiliation":[{"name":"Department of Rheumatology Swedish Health Services\/Providence St Joseph Health and University of Washington Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804595"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.12.036"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3908061"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.021"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14878"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1882-2"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15962"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1622678"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2020.04.001"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04046-0"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20141337"},{"key":"e_1_2_8_13_1","first-page":"778","article-title":"The risk of malignancy associated with psoriasis","volume":"137","author":"Margolis D","year":"2001","journal-title":"Arch Dermatol"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700410"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12165"},{"issue":"8","key":"e_1_2_8_16_1","first-page":"s216","article-title":"Psoriasis and psoriatic arthritis overview","volume":"22","author":"Menter A","year":"2016","journal-title":"Am J Manag Care"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.12.031"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2009.03.003"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP203604"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.06.056"},{"key":"e_1_2_8_21_1","unstructured":"U.S. Food & Drug Administration.Follow\u2010up to the June 4 2008 Early Communication about the Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade Enbrel Humira Cimzia and Simponi).2009. Available at:http:\/\/wayback.archive\u2010it.org\/7993\/20170112032013\/http:\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm174449.htm(last accessed 4 May 2021)."},{"key":"e_1_2_8_22_1","unstructured":"KlebanovN GuptaS GottliebAB MerolaAF.Predicting cancer survival outcomes of anti\u2010TNF IL\u201017 and IL\u201023 using gene expression data.American Academy of Dermatology2020 Virtual Meeting Experience (AAD VMX). Oral session."},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2004.11.006"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew314"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2742"},{"key":"e_1_2_8_26_1","first-page":"50","article-title":"Long\u2010term effects of interleukin\u201017A inhibition with secukinumab in active ankylosing spondylitis: 3\u2010year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial","volume":"36","author":"Baraliakos X","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.03.024"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14454"},{"key":"e_1_2_8_29_1","unstructured":"National Institutes of Health National Cancer Institute.Surveillance Epidemiology and End Results (SEER) Program. Incidence \u2013 SEER 21 Regs Limited\u2010Field Research Data + Hurricane Katrina Impacted Louisiana Cases with Delay Adjustment Malignant Only Nov 2018 Sub (2000\u20132016) In <Katrina\/Rita Population Adjustment> edn 2000\u20132016. Available at:https:\/\/seer.cancer.gov\/data\u2010software\/documentation\/seerstat\/nov2018\/(last accessed 7 May 2021)."},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.12.005"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.07.026"},{"key":"e_1_2_8_32_1","first-page":"1137","article-title":"Adverse drug events in infliximab\u2010treated patients compared with the general and psoriasis populations","volume":"7","author":"Menter A","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.07.013"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209270"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.07.040"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.041"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23738"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-019-00340-3"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-020-00512-4"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.19.2275"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.091025"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-46227-7_6"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01769.x"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23185"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940601)73:11<2759::AID-CNCR2820731118>3.0.CO;2-C"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1991.tb00314.x"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20129"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2904"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.11.1425"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21675"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.20136","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.20136","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.20136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:02:13Z","timestamp":1676365333000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/185\/5\/935\/6599981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1111\/bjd.20136"],"URL":"https:\/\/doi.org\/10.1111\/bjd.20136","archive":["Portico"],"relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"assertion":[{"value":"2021-04-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}